Naphthalene-based hydroxamate HDAC inhibitors with anti-breast tumor activity.

Song H, Wang FC, Liu WD, Wei QH, Yang F, Shan P, Zhang H

DOI: 10.1007/s11030-026-11607-1
Published: 2026 May 29
Container: Molecular diversity
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11030-026-11607-1,
  title = {Naphthalene-based hydroxamate HDAC inhibitors with anti-breast tumor activity.},
  author = {Song H and Wang FC and Liu WD and Wei QH and Yang F and Shan P and Zhang H},
  year = {2026},
  journal = {Molecular diversity},
  doi = {10.1007/s11030-026-11607-1},
  url = {https://doi.org/10.1007/s11030-026-11607-1}
}

RIS

TY  - JOUR
TI  - Naphthalene-based hydroxamate HDAC inhibitors with anti-breast tumor activity.
AU  - Song H
AU  - Wang FC
AU  - Liu WD
AU  - Wei QH
AU  - Yang F
AU  - Shan P
AU  - Zhang H
PY  - 2026
JO  - Molecular diversity
DO  - 10.1007/s11030-026-11607-1
UR  - https://doi.org/10.1007/s11030-026-11607-1
ER  -

APA

H, S., FC, W., WD, L., QH, W., F, Y., P, S., & H, Z. (2026). Naphthalene-based hydroxamate HDAC inhibitors with anti-breast tumor activity.. Molecular diversity. https://doi.org/10.1007/s11030-026-11607-1

Source records

pubmed · retrieved 2026-09-26T12:04:08.969Z
europe-pmc · retrieved 2026-09-26T12:04:08.960Z